Validation of the rapid ELISA method for determination of methyltestosterone in urine and muscle based on the new regulation (EU) 2021/808
Date Issued
2022-09-22
Author(s)
Jovanov, Stefan
Angeleska, Aleksandra
Stojanovska Dimzoska, Biljana
Abstract
Methyltestosterone is a synthetic anabolic steroid that can be used in meat
production animals to improve the weight gain and the meat/fat-ratio, but the residues
of this anabolic steroid in meat present a potential risk for public health. In the European
Union and most countries worldwide the use of methyltestosterone and other anabolic
steroids as growth promoter in livestock production is completely banned. In this study
an enzyme-linked immunosorbent assay (ELISA) screening method for detection of
methyltestosterone in urine and meat has been validated according to the Regulation (EU)
2021/808. Regulation (EU) 2021/808 is a new regulation that replaces the Commission
Decision 2002/657. The sample preparation procedure for urine involved hydrolysis
and clean-up with solid phase extraction (SPE) using C18 cartridges, while the sample
preparation for muscle included extraction with methanol, defatting with hexane and cleanup
with SPE using C18 cartridges. The concentrations of the residues were measured with
ELISA reader at 450 nm. In the validation procedure were included linearity, selectivity/
specifi city, limit of detection (LOD), decision limit (CCβ), trueness (expressed through
recovery) and precision (expressed through repeatability and reproducibility). The method
demonstrated excellent linearity with coeffi cient of variation (R2) 0.9966 for urine and
0.9997 for muscle, in the calibration range from 0.125 to 4.5 μg/L. The results for selectivity/
specifi city indicated that there are not matrix interferences. LOD was 0.25 μg/l for urine
and 0.25 μg/kg for muscle, while CCβ was 0.45 μg/l for urine and 0.60 μg/kg for muscle.
These values for CCβ were lower than new Minimum Method Performance Requirements
(MMPR) values for methyltestosterone. The new MMPR values for methyltestosterone,
which were adopted in 2020, for urine is 0.5 μg/l, while for muscle is 1.0 μg/kg. The
method yielded acceptable recovery rate between 70-120% in the fortifi ed samples from
urine and muscle. The coeffi cient of variation (CV) for repeatability was less than 15.0
%, while the CV for reproducibility was less than 20.0%. The method fulfi ls the criteria
prescribed in Regulation (EU) 2021/808 and can be used as rapid screening method for the
routine detection of methyltestosterone in urine and muscle.
production animals to improve the weight gain and the meat/fat-ratio, but the residues
of this anabolic steroid in meat present a potential risk for public health. In the European
Union and most countries worldwide the use of methyltestosterone and other anabolic
steroids as growth promoter in livestock production is completely banned. In this study
an enzyme-linked immunosorbent assay (ELISA) screening method for detection of
methyltestosterone in urine and meat has been validated according to the Regulation (EU)
2021/808. Regulation (EU) 2021/808 is a new regulation that replaces the Commission
Decision 2002/657. The sample preparation procedure for urine involved hydrolysis
and clean-up with solid phase extraction (SPE) using C18 cartridges, while the sample
preparation for muscle included extraction with methanol, defatting with hexane and cleanup
with SPE using C18 cartridges. The concentrations of the residues were measured with
ELISA reader at 450 nm. In the validation procedure were included linearity, selectivity/
specifi city, limit of detection (LOD), decision limit (CCβ), trueness (expressed through
recovery) and precision (expressed through repeatability and reproducibility). The method
demonstrated excellent linearity with coeffi cient of variation (R2) 0.9966 for urine and
0.9997 for muscle, in the calibration range from 0.125 to 4.5 μg/L. The results for selectivity/
specifi city indicated that there are not matrix interferences. LOD was 0.25 μg/l for urine
and 0.25 μg/kg for muscle, while CCβ was 0.45 μg/l for urine and 0.60 μg/kg for muscle.
These values for CCβ were lower than new Minimum Method Performance Requirements
(MMPR) values for methyltestosterone. The new MMPR values for methyltestosterone,
which were adopted in 2020, for urine is 0.5 μg/l, while for muscle is 1.0 μg/kg. The
method yielded acceptable recovery rate between 70-120% in the fortifi ed samples from
urine and muscle. The coeffi cient of variation (CV) for repeatability was less than 15.0
%, while the CV for reproducibility was less than 20.0%. The method fulfi ls the criteria
prescribed in Regulation (EU) 2021/808 and can be used as rapid screening method for the
routine detection of methyltestosterone in urine and muscle.
Subjects
File(s)![Thumbnail Image]()
Loading...
Name
Uzunov i dr dvm 2022.pdf
Size
2.05 MB
Format
Adobe PDF
Checksum
(MD5):7c3a39c5719fb8559a8246444320f23c